Document is current
Any future updates will be listed below
-
Authors
Géniès, Camille https://orcid.org/0000-0003-3535-4530
Maître, Martine
Baradat, Sophie
Froliger, Mélanie
Turlier, Virginie
Mercadié, Aurélie
Simcic-Mori, Aimée
Gravier, Eléonore
Lauze, Christophe
Huyghe, Céline
Alvarez-Georges, Sandrine
Chansard, Nathalie
Marinescu, Rasvan
Reygagne, Pascal
Bessou-Touya, Sandrine
Mengeaud, Valérie
Duplan, Hélène
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06578962 at ClinicalTrials.govDocuments that mention this clinical trial
Scalp Microbiome Dynamics Can Contribute to the Clinical Effect of a Novel Antiseborrheic Dermatitis Shampoo Containing Patented Antifungal Actives: A Randomized Controlled Study
https://doi.org/10.1007/s13555-025-01408-z
Metabolomics in Scalp Seborrheic Dermatitis Evidenced Key Changes in Inflammatory Markers Following a 10-Week Scalp Care Scheme with an Anti-dandruff Shampoo
https://doi.org/10.1007/s13555-026-01658-5
-
Funding
Funding for this research was provided by:
Les Laboratories Pierre Fabre
- License Information
-
More Information
Article History
Received: 17 November 2025
Accepted: 14 January 2026
First Online: 13 February 2026
Declarations
:
: Camille Géniès, Martine Maître, Sophie Baradat, Mélanie Froliger, Virginie Turlier, Aurélie Mercadié, Aimée Simcic-Mori, Eléonore Gravier, Christophe Lauze, Céline Huyghes, Sandrine Alvarez-Georges, Nathalie Chansard, Rasvan Marinescu, Pascal Reygagne, Sandrine Bessou-Touya, Valérie Mengeaud and Hélène Duplan are employees or were employees of Pierre Fabre Dermo-Cosmétique and Personal Care, France, at the time of the preparation of this manuscript and received salaries, but they do not have any financial interest in the findings described in this manuscript. Pascal Reygagne has previously received honorarium fees Pierre Fabre Dermo-Cosmétique and Personal Care for his role as a speaker, advisory board member and investigator but did not receive any financial compensation for the performance in this study.
: The study was performed in compliance with the Declaration of Helsinki and its subsequent amendments, as well as good clinical practice guidelines (CHMP/ICH/135/1995 and integrated addendum). It also conformed to Regulation (EC) No 1223/2009 of the European Commission and the French Decree (n°2017-884) pertaining to research on cosmetic products. As registration of studies evaluating cosmetic products is not mandatory in the European Union, the study was retrospectively registered under trial number NCT06578962 (August 28, 2024) for publication. Prior to enrolment, all subjects provided written informed consent.
